YorLabs, Inc.
PrivateLast Round
Series C
Oct 18, 2023
Total Funding Raised
$38.4M
Company Overview
YorLabs, Inc. operates in Healthcare & Life Sciences and is based in Beaverton, Oregon. Its latest recorded funding round was a Series C round in October 2023.
YorLabs, Inc. is a medical technology company that develops advanced intracardiac imaging and guidance systems for electrophysiology and interventional cardiology procedures.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Medical Imaging
Business Model
B2B
Customer Profile
Services & Consulting, Hardware Sales
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
YorLabs, Inc. Comparables
Compare YorLabs, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| LUMA Vision | 86% | |
| Shifamed | 79% | |
| Conavi Medical Corp. | 77% |
For institutional investors. Book with your work email.
YorLabs, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Oct 18, 2023 | ||||
| Series B | Oct 25, 2021 | ||||
| Seed | Aug 12, 2020 | ||||
| Debt | Apr 13, 2020 | ||||
| Seed | Nov 6, 2019 | ||||
Debt | Mar 22, 2019 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
YorLabs, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Vectr Ventures | Seed, Series C |
| TiE Oregon | Series C |
| Synergy Life Science Partners | Seed |
| ShangBay Capital | Series B, Series C |
| Globaleye Ventures | Series C |
| Bioworld Ventures | Seed |
| TiE | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 30, 2024
Monthly visitors increased 97% MoM.
- Oct 18, 2023
$17.3M round with participation from Globaleye Ventures and ShangBay Capital.
For institutional investors. Book with your work email.
YorLabs, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about YorLabs, Inc.'s valuation, stock price, and market status.
Is YorLabs, Inc. a public or private company?
YorLabs, Inc. is a private company.
What is the current stock price of YorLabs, Inc.?
YorLabs, Inc. is a private company, so its shares have no public market price. Caplight tracks YorLabs, Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is YorLabs, Inc. worth (valuation)?
Valuation information for YorLabs, Inc. is not publicly available.
Can I buy YorLabs, Inc. stock?
YorLabs, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was YorLabs, Inc.'s last funding round?
YorLabs, Inc.'s most recent funding round was Series C on October 18, 2023.
Who are the main investors in YorLabs, Inc.?
Key investors in YorLabs, Inc. include Vectr Ventures, TiE Oregon, Synergy Life Science Partners, ShangBay Capital, Globaleye Ventures.
Will YorLabs, Inc. IPO soon?
No public IPO plans have been announced for YorLabs, Inc..
How can I track YorLabs, Inc. secondary market activity?
Caplight tracks bids, offers, and trades in YorLabs, Inc.'s shares on secondary markets.